Found: 87
Select item for more details and to access through your institution.
Aquaporin-4-Antikörper-positive-Neuromyelitis-optica-Spektrum-Erkrankungen und Myelinoligodendrozytenglykoprotein-Antikörper-assoziierte Enzephalomyelitis. Eine Kurzübersicht.
- Published in:
- Der Nervenarzt, 2021, v. 92, n. 4, p. 317, doi. 10.1007/s00115-021-01106-z
- By:
- Publication type:
- Article
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study).
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 7, p. 819, doi. 10.1177/13524585231151212
- By:
- Publication type:
- Article
Humoral COVID-19 vaccine response in patients with NMOSD/MOGAD during anti-IL-6 receptor therapy compared to other immunotherapies.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 757, doi. 10.1177/13524585221151124
- By:
- Publication type:
- Article
Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 331, doi. 10.1177/1352458517699791
- By:
- Publication type:
- Article
Olfactory Dysfunction in Patients with Neuromyelitis Optica.
- Published in:
- Multiple Sclerosis International, 2013, p. 1, doi. 10.1155/2013/654501
- By:
- Publication type:
- Article
Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
- Published in:
- Journal of Neuroinflammation, 2014, v. 11, n. 1, p. 167, doi. 10.1186/s12974-014-0206-3
- By:
- Publication type:
- Article
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.
- Published in:
- Journal of Neuroinflammation, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1742-2094-11-46
- By:
- Publication type:
- Article
Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The history of neuromyelitis optica.
- Published in:
- Journal of Neuroinflammation, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1742-2094-10-8
- By:
- Publication type:
- Article
The history of neuromyelitis optica.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxia.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Cerebrospinal fluid antibodies to aquaporin-4 inneuromyelitis optica and related disorders:frequency, origin, and diagnostic relevance.
- Published in:
- Journal of Neuroinflammation, 2010, v. 7, p. 52, doi. 10.1186/1742-2094-7-52
- By:
- Publication type:
- Article
A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization.
- Published in:
- Journal of Neuroinflammation, 2010, v. 7, p. 21, doi. 10.1186/1742-2094-7-21
- By:
- Publication type:
- Article
Th17 cells: A prognostic marker for MS rebound after natalizumab cessation?
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 1, p. 114, doi. 10.1177/1352458516640609
- By:
- Publication type:
- Article
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in ‘pattern II multiple sclerosis’ and brain biopsy findings in a MOG-IgG-positive case.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 12, p. 1541, doi. 10.1177/1352458515622986
- By:
- Publication type:
- Article
Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 12, p. 1521, doi. 10.1177/1352458514564589
- By:
- Publication type:
- Article
Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 9, p. 1189, doi. 10.1177/1352458513519838
- By:
- Publication type:
- Article
Visual evoked potentials in neuromyelitis optica and its spectrum disorders.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 5, p. 617, doi. 10.1177/1352458513503053
- By:
- Publication type:
- Article
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 11, p. 1592, doi. 10.1177/1352458512441270
- By:
- Publication type:
- Article
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
- Published in:
- Multiple Sclerosis Journal, 2011, v. 17, n. 9, p. 1067, doi. 10.1177/1352458511403958
- By:
- Publication type:
- Article
Effect of storage conditions and freeze/thaw cycles on aquaporin-4 antibody (NMO-IgG) serum levels.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2011, v. 49, n. 12, p. 2121, doi. 10.1515/CCLM.2011.717
- By:
- Publication type:
- Article
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 600, doi. 10.1093/brain/awac090
- By:
- Publication type:
- Article
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
- Published in:
- Annals of Neurology, 2024, v. 95, n. 4, p. 720, doi. 10.1002/ana.26858
- By:
- Publication type:
- Article
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis.
- Published in:
- Acta Neuropathologica, 2021, v. 141, n. 1, p. 127, doi. 10.1007/s00401-020-02236-5
- By:
- Publication type:
- Article
7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 8, p. 900, doi. 10.1002/acn3.572
- By:
- Publication type:
- Article
Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01204
- By:
- Publication type:
- Article
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study.
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.499910
- By:
- Publication type:
- Article
Evaluation of aquaporin-4 antibody assays.
- Published in:
- Clinical & Experimental Neuroimmunology, 2014, v. 5, n. 3, p. 290, doi. 10.1111/cen3.12107
- By:
- Publication type:
- Article
Leptomeningeal and Intraparenchymal Blood Barrier Disruption in a MOG-IgG Positive Patient.
- Published in:
- Case Reports in Neurological Medicine, 2018, p. 1, doi. 10.1155/2018/1365175
- By:
- Publication type:
- Article
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 59, doi. 10.1007/s00415-023-12092-4
- By:
- Publication type:
- Article
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 1, p. 141, doi. 10.1007/s00415-023-11910-z
- By:
- Publication type:
- Article
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 7, p. 3341, doi. 10.1007/s00415-023-11634-0
- By:
- Publication type:
- Article
Rho GTPase-activating protein 17 (ARHGAP17) as additional autoimmune target in ARHGAP26-IgG/anti-Ca autoantibody-associated autoimmune encephalitis.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 3, p. 1776, doi. 10.1007/s00415-022-11417-z
- By:
- Publication type:
- Article
Rho GTPase-activating protein 10 (ARHGAP10/GRAF2) is a novel autoantibody target in patients with autoimmune encephalitis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5420, doi. 10.1007/s00415-022-11178-9
- By:
- Publication type:
- Article
COVID-19-related severe MS exacerbation with life-threatening Takotsubo cardiomyopathy in a previously stable patient and interference of MS therapy with long-term immunity against SARS-CoV-2.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 3, p. 1138, doi. 10.1007/s00415-021-10779-0
- By:
- Publication type:
- Article
Cell-based assays for the detection of MOG antibodies: a comparative study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 12, p. 3555, doi. 10.1007/s00415-020-10024-0
- By:
- Publication type:
- Article
Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 3, p. 715, doi. 10.1007/s00415-019-09614-4
- By:
- Publication type:
- Article
Low intrathecal antibody production despite high seroprevalence of Epstein–Barr virus in multiple sclerosis: a review of the literature.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 2, p. 239, doi. 10.1007/s00415-017-8656-z
- By:
- Publication type:
- Article
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
- Published in:
- Journal of Neurology, 2016, v. 263, n. 3, p. 575, doi. 10.1007/s00415-015-7991-1
- By:
- Publication type:
- Article
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
- Published in:
- Journal of Neurology, 2015, v. 262, n. 5, p. 1379, doi. 10.1007/s00415-015-7766-8
- By:
- Publication type:
- Article
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS).
- Published in:
- Journal of Neurology, 2014, v. 261, n. 1, p. 1, doi. 10.1007/s00415-013-7169-7
- By:
- Publication type:
- Article
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Anti-Ma2/Ta antibodies in a woman with primary lateral sclerosis-like phenotype and Sjögren syndrome.
- Published in:
- Neurological Sciences, 2011, v. 32, n. 5, p. 915, doi. 10.1007/s10072-011-0510-y
- By:
- Publication type:
- Article
Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066151
- By:
- Publication type:
- Article